Listing in London – King & Spalding carries US biotech to AIM listing Legal Business11 May 2015Corporate and M&AUS King & Spalding’s recent recruits in the City have helped handle Californian biotech company Verseon £300m stock market listing in London while Covington & Burling advised from San Francisco.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this categoryTrading Places: Cleary hires A&O Shearman capital markets duo as Freshfields tech M&A pair move to CovingtonKing & Spalding posts near-50% London revenue hike as PEP passes $7m markRevolving Doors: Latham, Proskauer, Weil build PE teams as US stays focused on EuropeFreshfields takes headline role on £575m Telegraph acquisitionDLA Piper and Proskauer lead on BrewDog’s sale to US cannabis and drinks manufacturerPaul Hastings hires London M&A partner from Slaughter and MayClifford Chance names Cohen first New York managing partner amid fresh bid to crack America with Houston office openingInternational Women’s Day 2022: Barbara L. Becker, chair & managing partner, Gibson Dunn, New YorkInternational Women’s Day 2022: Perlette Jura, Gibson Dunn, Los Angeles – disputes